NYSE:DVA - Davita Stock Price, News & Analysis

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

Davita announced that its board has authorized a stock buyback plan on Wednesday, October 11th 2017, which permits the company to buyback $1,500,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Stock buyback plans are generally an indication that the company's board believes its shares are undervalued.

Davita Inc (NYSE:DVA) posted its quarterly earnings data on Thursday, August, 1st. The company reported $1.22 earnings per share for the quarter, beating analysts' consensus estimates of $1.10 by $0.12. The firm had revenue of $2.84 billion for the quarter, compared to analysts' expectations of $2.86 billion. Davita had a net margin of 1.21% and a return on equity of 14.67%. Davita's quarterly revenue was down 1.5% compared to the same quarter last year. During the same period last year, the company earned $1.05 EPS. View Davita's Earnings History.

Davita is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for Davita.

9 Wall Street analysts have issued 12-month target prices for Davita's shares. Their predictions range from $59.00 to $70.00. On average, they anticipate Davita's share price to reach $64.74 in the next twelve months. This suggests a possible upside of 12.0% from the stock's current price. View Analyst Price Targets for Davita.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Davita in the last year. There are currently 6 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Davita.

Media stories about DVA stock have trended negative this week, InfoTrie reports. The research group identifies positive and negative media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Davita earned a media sentiment score of -2.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Davita.

Davita saw a drop in short interest during the month of July. As of July 31st, there was short interest totalling 9,074,800 shares, a drop of 5.4% from the June 30th total of 9,590,100 shares. Based on an average trading volume of 2,240,000 shares, the days-to-cover ratio is presently 4.1 days. Approximately 5.6% of the shares of the company are short sold. View Davita's Current Options Chain.

Some companies that are related to Davita include Fresenius Medical Care AG & Co. (FMS), Livongo Health (LVGO), Tivity Health (TVTY), Catasys (CATS), American Renal Associates (ARA), HemaCare (HEMA), Emmaus Life Sciences (EMMA), Caladrius Biosciences (CLBS), Pacific Health Care Organization (PFHO), MYnd Analytics (MYND), BioRestorative Therapies (BRTX) and American Caresource (GNOW).

Based on aggregate information from My MarketBeat watchlists, some companies that other Davita investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), AutoZone (AZO), Designer Brands (DSW), Precision Drilling (PD), Micron Technology (MU) and Och-Ziff Capital Management Group (OZM).

Davita's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (8.52%), BlackRock Inc. (7.60%), Par Capital Management Inc. (2.59%), Invesco Ltd. (2.28%), Viking Global Investors LP (1.81%) and Camber Capital Management LP (1.25%). Company insiders that own Davita stock include Charles Berg, James K Hilger, Javier Rodriguez, Kent J Thiry, Leanne M Zumwalt, Pamela M Arway and William L Roper. View Institutional Ownership Trends for Davita.

DVA stock was sold by a variety of institutional investors in the last quarter, including TIG Advisors LLC, AQR Capital Management LLC, Price T Rowe Associates Inc. MD, BlackRock Inc., First Trust Advisors LP, Schroder Investment Management Group, Schroder Investment Management Group and Canada Pension Plan Investment Board. View Insider Buying and Selling for Davita.

DVA stock was bought by a variety of institutional investors in the last quarter, including Invesco Ltd., Par Capital Management Inc., Pictet Asset Management Ltd., DekaBank Deutsche Girozentrale, Camber Capital Management LP, Nuveen Asset Management LLC, Tavio Capital LLC and SkyTop Capital Management LLC. View Insider Buying and Selling for Davita.

Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of DVA stock can currently be purchased for approximately $57.82.

Davita has a market capitalization of $9.27 billion and generates $11.40 billion in revenue each year. The company earns $159.39 million in net income (profit) each year or $3.57 on an earnings per share basis. Davita employs 77,700 workers across the globe.View Additional Information About Davita.

The official website for Davita is http://www.davita.com/.

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 720-631-2100 or via email at [email protected]